ARCHIVES

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

This article is from The Cancer Letter archive.

Vol. 39 No. 42 | November 8, 2013

Download PDF Visit The Full Archive

Related Articles

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

April 30, 2010

In Brief: Masnyk Named DCBD Deputy Director Maizel to Head NCI’s “Supercomputer” Development

November 2, 1984

NCI’s Rosenberg Confirms 2002 Immunotherapy Results

April 29, 2005

NCAB Meeting Moved To October

July 20, 1979

In Brief: Wittes To Return To NCI As Chief Of Medicine Branch; Owens Heads Cancer Research Coalition

June 8, 1990

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

November 13, 1992